Literature DB >> 339674

Hemodynamic effect of long--term treatment with pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm.

J H Atterhög, H Dunér, B Pernow.   

Abstract

Ten patients with essential hypertension have been studied at rest, during and after exercise following oral treatment for on an average 16 months with a beta-adrenoreceptor blocking agent, pindolol. The study was a direct continuation of an earlier, performed after 2 months' treatment. The hypotensive effect of pindolol was highly significant after 2 as well as 16 months of treatment. Heart rate was similarly lowered at 2 and 16 months, while carciac output, which was significantly lower during exercise after 2 months, had increased to the pretreatment level after 16 months. Peripheral vascular resistance, which was not affected after 2 months, had decreased significantly during and after exercise in the long-term study. A comparison between the hemodynamic situations after 2 and 16 months thus suggests that while a decrease in cardiac output is an early mechanism in the lowering of BP, changes in systemic vascular resistance seem to be more important after long-term treatment with pindolol.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 339674     DOI: 10.1111/j.0954-6820.1977.tb16874.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  8 in total

1.  Haemodynamic differences in untreated hypertension and hypertension treated with various beta-adrenoceptor antagonists.

Authors:  C Weil; R Waite
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 2.  Reversibility of structural changes in the resistance vessels in hypertension: a review of studies with pindolol.

Authors:  H Duner
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

3.  Acute and long-term antihypertensive effect of bopindolol--a nonselective beta-adrenergic blocker with ISA.

Authors:  O K Andersson; T Hedner; G Nyberg
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Vasodilating properties of beta-adrenoceptor blockers with intrinsic sympathomimetic activity.

Authors:  O Thulesius; J E Gjöres; E Berlin
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 5.  Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

6.  Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.

Authors:  D H Roberts; Y Tsao; S F Grimmer; P A Winstanley; M L Orme; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

7.  Haemodynamic effects of metoprolol and pindolol: a comparison in hypertensive patients.

Authors:  A Svensson; T Gudbrandsson; R Sivertsson; L Hansson
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

8.  Effects of acute and long-term beta-adrenoceptor blockade with propranolol on haemodynamics, plasma catecholamines and renin in essential hypertension.

Authors:  M A van Baak; T L Kho; H Thijssen; K H Rahn
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.